A case-reference study on plasma fibhnogen concentrations and coronary atherosclerosis in Japanese

Journal of Epidemiology

Volumn 6, Issue 2, 1996, Pages 81-86

  Sato, Shinichi ^a   Kobayashi, Toru ^a,c   Lida, Minoru ^a,b,c   Naito, Yoshihiko ^a,b,c   Kiyama, Masahiko ^a   Kitamura, Akihiko ^a   Iso, Hiroyasu ^a,b,c   Komachi, Yoshio ^a,b,c  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Coronary artery stenosis; Cross sectional study; Japanese; Myocardial infarction; Plasma fibrinogen

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; FEMALE; HEART INFARCTION; HUMAN; JAPAN; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 34547110742     PISSN: 09175040     EISSN: None     Source Type: Journal    
DOI: 10.2188/jea.6.81     Document Type: Article

References (43)

1. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events : final report of the Pooling Project. J Chron Dis 1978 ;31 : 201-306.
2. WHO Expert Committee on Prevention of Coronary Heart Disease. Prevention of Coronary Heart Disease : World Health Organization Technical Report Series 678. Geneva : World Health Organization, 1982.
3. Gordon T, Catelli WP, Hjortland MC, Kännel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease : the Framingham Study. Am J Med 1977 ; 62:707-714.
4. Goldbourt U, Medalie JH. High density lipoprotein cholesterol and incidence of coronary heart disease : the Israeli Ischémie Heart Disease Study. Am J Epidemiol 1979 ; 109:296-308.
5. Enger SC, H jermann I, Foss OP, et al. High density lipoproteincholesterol and myocardial infarction or sudden coronary death : a prospective case-control study in middle-aged men of Oslo study. Artery 1979 ; 5 : 170181.
6. Jacobs DRJr, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women : the follow-up study of the Lipid Research Clinics Study. Am J Epidemiol 1990 ; 131 : 32-47.
7. Meade TW, North WRS, Chakrabarti R, et al. Haemostatic function and cardiovascular death : Early results of a prospective study. Lancet 1980 ; i : l OSO1054.
8. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease : Principal results of the Northwick Park Heart Study. Lancet 1986 ; ii : 533537.
9. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984 ; 311:501-505.
10. Stone MC, Thorp JM. Plasma fibrinogen - a major coronary risk factor. J R Coll Gen Pract 1985 ; 35 :565-569.
11. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987 ; 258 : 1183-1186.
12. Yamell JWG, Baker IA, Sweetnam PM, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemie heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation 1991 ; 83 : 836-844.
13. Konishi M, lida M, Naito Y, et al. The trend of coronary heart disease and its risk factors based on epidemiological investigations. Jpn Cire J 1987 ; 51:319-324.
14. Kitamura A, Iso H, Naito Y, et al. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 1994 ; 89:2533-2539.
15. Sato S, Iso H, Naito Y, et al. Plasma fibrinogen and its correlates in urban Japanese men. Int J Epidemiol 1996 ; 25 : (in printing).
16. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study : design and objectives. Am J Epidemiol 1989 ; 129:687-702.
17. Clauss A. Gennungsphysiologishe Schnellmethode sur Bestimmung des Fibrinogens. Acta Haematol 1957 ; 17 : 237-246.
18. Colesterol (Enzymatic-II) : Technicon AutoAnalyzer II, Method No. SE4-0065FB1, February 1981.
19. Colesterol (Direct) : Technicon AutoAnalyzer II, Method No. SE4-0026FC4, March 1974.
20. U.S. Dept. of Health and Human Services. CDC-NHLBI Lipid Std. Program, CDC. (USA) 1980.
21. Kirkendall WM, Feinlieb M, Preis ED, Mark AL. Recommendations for human blood pressure determination by sphygmomanometers. Subcommittee of the AHA Postgraduate Education Committee. Circulation 1980 ; 62:1146A-1155A.
22. Korsan-Bengtsen K, Wilhelmsen L, Elmfeldt D, Tibblin G. Blood coagulation and fibrinolysis in men after myocardial infarction compared %vith a representative population sample. Atherosclerosis 1972 ; 16: 83-88.
23. Nicolaides AN, Bowers R, Horbourne T, Kidner PH, Besterman EM. Blood viscosity, red-cell flexibirity, haematocrit, and plasma-fibrinogen in patients with angina. Lancetl 1977:943-945.
24. Löwe GDO, Drummond MM, Lorimer AR, et al. Relation between extent of coronary artery disease and blood viscosity. Br Med J 1980 ; 280:673-674.
25. Yarnell JWG, Sweetnam PM, Elwood PC, et al. Haemostatic factors and ischaemic heart disease. The Caerphilly Study. Br Heart J 1985 ; 53 :483-487.
26. Lowe GDO, Wood DA, Douglas JT, et al. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thromb Haemost 1991 ; 65 : 339-343.
27. Handa K, Kono S, Saku K, et al. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. Atherosclerosis 1989 ; 77 :209-213.
28. Feher MD, Rampling MW, Brown J, et al. Acute changes in atherogenic and thrombogenic factors with cessation of smoking. J Royal Soc Med 1990 ; 83 : 146-148.
29. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987 ; ii : 986988.
30. Lee AJ, Smith WCS, Löwe GDO, Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors : the Scottish Heart Health Study. J Clin Epidemiol 1990 ; 43 : 913919.
31. Dobson AJ, Alexander HM, Heller RF, Lloyd DM. How soon after quitting smoking does risk of heart attack decline? J Clin Epidemiol 1991 ;44: 1247-1253.
32. Meade TW, Chakrabarti R, Haines AP, North WRS.Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979 ; 1: 153-156.
33. Balleisen L, Bailey J, Epping PH, Schulte H, van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population : I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using and menopause. Thromb Haemostas 1985 ; 54:475-479.
34. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 1987 ; 113:1006-1010.
35. Folsom AR, Wu KK, Davis CE, Conlan MG, Sortie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991 ;91 : 191-205.
36. Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen : relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg Survey, 1989-1990. Arterioscler and Thrombo 1992 ; 12 : 780788.
37. Brunner El, Marmot MG, White IR, et al. Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II Study. Atherosclerosis 1993 ; 102: 195-207.
38. Yarnell JWG, Sweetnam PM, Rogers S, et al. Some longterm effects of smoking on the haemostatic system : a report from the Caerphilly and Speedwell Collaborative Surveys. J Clin Pathol 1987 ; 40: 909-913.
39. Wilkes HE, Kelleher C, Meade TW. Smoking and plasma fibrinogen (letter to the Editor). Lancet 1988 ; 1 : 307-308.
40. Bonithon-Kopp C, Scarabin P-Y, Bara L, et al. Relationship between sex hormones and haemostatic factors in healthy middle-aged men. Atherosclerosis 1988 ; 71:71-76.
41. Balleisen L, Assmann G, Bailey J, et al. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population : I. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions. Thromb Haemost 1985 ; 54:721-723.
42. Moller L, Kristensen TS. Plasma fibrinogen and ischaemic heart disease risk factors. Arterioscler Thromb 1991; 11:344-350.
43. Iso H, Folsom AR, Sato S, et al. Plasma fibrinogen and its correlates in Japanese and U. S. population samples. Arterios Thromb 1993 ; 13 :783-790.